Bioenergetic Signature Predicts Cancer Cell Death Response
Author Information
Author(s): María Sánchez-Aragó, José M. Cuezva
Primary Institution: Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid
Hypothesis
The bioenergetic signature of isogenic colon cancer cells can predict their response to treatment with metabolic inhibitors and chemotherapeutic agents.
Conclusion
The bioenergetic signature of colon cancer cells can help predict their response to different cancer treatments.
Supporting Evidence
- The bioenergetic signature inversely correlates with necrosis in response to glycolytic inhibitors.
- The bioenergetic signature directly correlates with apoptosis in response to 5-FU treatment.
- In vivo tumor regression activities of 3BrP, IA, and 5-FU were comparable despite differences in vitro.
Takeaway
Scientists found that the energy use pattern of colon cancer cells can tell us how likely they are to die when treated with certain drugs.
Methodology
The study used western blotting to determine the bioenergetic signature, flow cytometry for cell death analysis, and a xenograft mouse model for in vivo tumor regression assessment.
Limitations
The in vitro results may not fully predict in vivo outcomes due to additional mechanisms affecting tumor regression.
Participant Demographics
Isogenic HCT116 colon cancer cell lines were used, representing different bioenergetic signatures.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website